-
1
-
-
23444437213
-
Convection-enhanced delivery of macromolecules in the brain
-
Bobo R.H., Laske D.W., Akbasak A., Morrison P.F., Dedrick R.L., Oldfield E.H. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 1994, 91:2076-2080.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 2076-2080
-
-
Bobo, R.H.1
Laske, D.W.2
Akbasak, A.3
Morrison, P.F.4
Dedrick, R.L.5
Oldfield, E.H.6
-
2
-
-
0032949676
-
Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time
-
Chen M.Y., Lonser R.R., Morrison P.F., Governale L.S., Oldfield E.H. Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg 1999, 90:315-320.
-
(1999)
J Neurosurg
, vol.90
, pp. 315-320
-
-
Chen, M.Y.1
Lonser, R.R.2
Morrison, P.F.3
Governale, L.S.4
Oldfield, E.H.5
-
3
-
-
0038249170
-
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
-
Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003, 9:589-595.
-
(2003)
Nat Med
, vol.9
, pp. 589-595
-
-
Gill, S.S.1
Patel, N.K.2
Hotton, G.R.3
O'Sullivan, K.4
McCarter, R.5
Bunnage, M.6
-
4
-
-
79952110122
-
A magnetic resonance imaging-directed method for transventricular targeting of midline structures for deep brain stimulation using implantable guide tubes
-
discussion 7
-
Khan S., Javed S., Park N., Gill S.S., Patel N.K. A magnetic resonance imaging-directed method for transventricular targeting of midline structures for deep brain stimulation using implantable guide tubes. Neurosurgery 2010, 66:234-237. discussion 7.
-
(2010)
Neurosurgery
, vol.66
, pp. 234-237
-
-
Khan, S.1
Javed, S.2
Park, N.3
Gill, S.S.4
Patel, N.K.5
-
5
-
-
78149479157
-
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
-
Kunwar S., Chang S., Westphal M., Vogelbaum M., Sampson J., Barnett G., et al. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 2010, 12:871-881.
-
(2010)
Neuro Oncol
, vol.12
, pp. 871-881
-
-
Kunwar, S.1
Chang, S.2
Westphal, M.3
Vogelbaum, M.4
Sampson, J.5
Barnett, G.6
-
6
-
-
33947547455
-
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group
-
Kunwar S., Prados M.D., Chang S.M., Berger M.S., Lang F.F., Piepmeier J.M., et al. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 2007, 25:837-844.
-
(2007)
J Clin Oncol
, vol.25
, pp. 837-844
-
-
Kunwar, S.1
Prados, M.D.2
Chang, S.M.3
Berger, M.S.4
Lang, F.F.5
Piepmeier, J.M.6
-
7
-
-
0032747338
-
Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics
-
Morrison P.F., Chen M.Y., Chadwick R.S., Lonser R.R., Oldfield E.H. Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics. Am J Physiol 1999, 277:R1218-R1229.
-
(1999)
Am J Physiol
, vol.277
-
-
Morrison, P.F.1
Chen, M.Y.2
Chadwick, R.S.3
Lonser, R.R.4
Oldfield, E.H.5
-
8
-
-
0028144703
-
High-flow microinfusion: tissue penetration and pharmacodynamics
-
Morrison P.F., Laske D.W., Bobo H., Oldfield E.H., Dedrick R.L. High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol 1994, 266:R292-R305.
-
(1994)
Am J Physiol
, vol.266
-
-
Morrison, P.F.1
Laske, D.W.2
Bobo, H.3
Oldfield, E.H.4
Dedrick, R.L.5
-
9
-
-
77958451895
-
A novel coaxial tube catheter for central nervous system infusions: performance characteristics in brain phantom gel
-
Panse S.J., Fillmore H.L., Chen Z.J., Gillies G.T., Broaddus W.C. A novel coaxial tube catheter for central nervous system infusions: performance characteristics in brain phantom gel. J Med Eng Technol 2010, 35:408-414.
-
(2010)
J Med Eng Technol
, vol.35
, pp. 408-414
-
-
Panse, S.J.1
Fillmore, H.L.2
Chen, Z.J.3
Gillies, G.T.4
Broaddus, W.C.5
-
10
-
-
13144282676
-
Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study
-
Patel N.K., Bunnage M., Plaha P., Svendsen C.N., Heywood P., Gill S.S. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann Neurol 2005, 57:298-302.
-
(2005)
Ann Neurol
, vol.57
, pp. 298-302
-
-
Patel, N.K.1
Bunnage, M.2
Plaha, P.3
Svendsen, C.N.4
Heywood, P.5
Gill, S.S.6
-
11
-
-
85052608961
-
GDNF delivery for Parkinson's disease
-
Patel N.K., Gill S.S. GDNF delivery for Parkinson's disease. Acta Neurochir (Wien) 2007, 97:135-154.
-
(2007)
Acta Neurochir (Wien)
, vol.97
, pp. 135-154
-
-
Patel, N.K.1
Gill, S.S.2
-
12
-
-
37348999273
-
Magnetic resonance imaging-directed method for functional neurosurgery using implantable guide tubes
-
discussion 65-6
-
Patel N.K., Plaha P., Gill S.S. Magnetic resonance imaging-directed method for functional neurosurgery using implantable guide tubes. Neurosurgery 2007, 61:358-365. discussion 65-6.
-
(2007)
Neurosurgery
, vol.61
, pp. 358-365
-
-
Patel, N.K.1
Plaha, P.2
Gill, S.S.3
-
13
-
-
33750609664
-
Point source concentration of GDNF may explain failure of phase II clinical trial
-
Salvatore M.F., Ai Y., Fischer B., Zhang A.M., Grondin R.C., Zhang Z., et al. Point source concentration of GDNF may explain failure of phase II clinical trial. Exp Neurol 2006, 202:497-505.
-
(2006)
Exp Neurol
, vol.202
, pp. 497-505
-
-
Salvatore, M.F.1
Ai, Y.2
Fischer, B.3
Zhang, A.M.4
Grondin, R.C.5
Zhang, Z.6
-
14
-
-
77955608850
-
Poor drug distribution as a possible explanation for the results of the PRECISE trial
-
Sampson J.H., Archer G., Pedain C., Wembacher-Schroder E., Westphal M., Kunwar S., et al. Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg 2010, 113:301-309.
-
(2010)
J Neurosurg
, vol.113
, pp. 301-309
-
-
Sampson, J.H.1
Archer, G.2
Pedain, C.3
Wembacher-Schroder, E.4
Westphal, M.5
Kunwar, S.6
-
15
-
-
34547500147
-
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions
-
Sampson J.H., Raghavan R., Brady M.L., Provenzale J.M., Herndon J.E, Croteau D., et al. Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Neuro Oncol 2007, 9:343-353.
-
(2007)
Neuro Oncol
, vol.9
, pp. 343-353
-
-
Sampson, J.H.1
Raghavan, R.2
Brady, M.L.3
Provenzale, J.M.4
Herndon, J.E.5
Croteau, D.6
-
16
-
-
37349110365
-
Convection-enhanced delivery of cintredekin besudotox (interleukin-13-Pe38qqr) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results
-
discussion 1037-8
-
Vogelbaum M.A., Sampson J.H., Kunwar S., Chang S.M., Shaffrey M., Asher A.L., et al. Convection-enhanced delivery of cintredekin besudotox (interleukin-13-Pe38qqr) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery 2007, 61:1031-1037. discussion 1037-8.
-
(2007)
Neurosurgery
, vol.61
, pp. 1031-1037
-
-
Vogelbaum, M.A.1
Sampson, J.H.2
Kunwar, S.3
Chang, S.M.4
Shaffrey, M.5
Asher, A.L.6
-
17
-
-
78650928901
-
A robust MRI-compatible system to facilitate highly accurate stereotactic administration of therapeutic agents to targets within the brain of a large animal model
-
White E., Woolley M., Bienemann A., Johnson D.E., Wyatt M., Murray G., et al. A robust MRI-compatible system to facilitate highly accurate stereotactic administration of therapeutic agents to targets within the brain of a large animal model. J Neurosci Methods 2011, 195:78-87.
-
(2011)
J Neurosci Methods
, vol.195
, pp. 78-87
-
-
White, E.1
Woolley, M.2
Bienemann, A.3
Johnson, D.E.4
Wyatt, M.5
Murray, G.6
|